Akanda Corp. Common Shares (AKAN)
AKAN trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.38
-15.85% on the day
Market cap
$3.3M
Nano cap
Revenue · 2024
$837K
No prior year to compare
Net income · 2024
-$4.1M
-489.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2024-12-31, https://www.sec.gov/Archives/edgar/data/1888014/000121390025037490/0001213900-25-037490-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), period ending 2024-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | AKAN on Nasdaq |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | United Kingdom |
| IPO year | 2022 |
| SEC CIK | 0001888014 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Incorporated in | A6 |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $837K |
| Net income | -$4.1M |
| Operating income | Not in SEC XBRL data |
| Net margin | -489.6% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.9× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | F-1 | 2026-10-01 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-06-09 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-09-30 |
Source: SEC EDGAR submissions feed, 198 recent filings. All filings on EDGAR.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IMCC | IM Cannabis Corp. Common Shares | $1.36 | -6.85% | $2.2M |
| NAII | Natural Alternatives International Inc. | $1.15 | -5.74% | $7.2M |
| BON | Bon Natural Life Limited | $1.12 | -0.76% | $9.1M |
| MTEX | Mannatech Incorporated | $7.56 | -2.95% | $14.6M |
| XXII | 22nd Century Group Inc. | $0.6666 | -7.98% | $476K |
| BTMD | Biote Corp. | $1.04 | -8.77% | $37.4M |
| ISPR | Ispire Technology Inc. | $1.45 | -1.36% | $83.7M |
| FTLF | FitLife Brands Inc. | $9.07 | -1.73% | $85.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier